This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

China trade grows in July; Asean leads as top partner while trade with US falls

( August 7, 2025, 07:33 GMT | Official Statement) -- MLex Summary: China's total trade rose 6.7 percent in July to 3.91 trillion yuan ($540 billion), with exports up 8 percent and imports climbing 4.8 percent for a second consecutive month, customs data showed today. In the first seven months of 2025, the Association of Southeast Asian Nations, or Asean, remained China's largest trading partner, with trade up 9.4 percent to 4.29 trillion yuan, accounting for 16.7 percent of total trade. The European Union ranked second, while trade with the US fell 11.1 percent to 2.42 trillion yuan, making it China's third-largest partner. Export growth was led by electronics, including data-processing devices, integrated circuits and automobiles. Imports of key commodities such as iron ore, crude oil and natural gas fell in value amid lower global prices.The statement follows:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections